College of Pharmacy, Yeungnam University, Gyeongsan, Republic of Korea.
Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia.
J Hosp Infect. 2022 Nov;129:124-143. doi: 10.1016/j.jhin.2022.07.031. Epub 2022 Aug 12.
Antimicrobial stewardship (AMS) interventions to improve antibiotic use are being implemented in Africa, but their impact is not fully known. The aim of this review was to estimate the effectiveness of interventions to improve antibiotic prescribing for hospital inpatients. Studies from PubMed, Embase, African Journals Online and Google Scholar were systematically searched from January 2010 to July 2022. Studies were included if they reported the impact of AMS interventions on outcomes of interest for hospital inpatients in Africa. Risk of bias was evaluated using the Cochrane Effective Practice and Organization of Care guidelines and the National Heart, Lung and Blood Institute tool. Findings were summarized in tables and meta-analyses were performed using random-effects models. A total of 28 studies were included, 89% being uncontrolled before and after studies. Most interventions employed were multi-faceted and found to be effective, evidenced by increased compliance, reduction in antibiotic utilization and cost, and slight reduction or no difference in mortality and length of hospital stay (LOS). Meta-analysis generated a relative risk of 0.82 [95% confidence interval (CI) 0.70-0.97] for mortality, and a standard mean difference of -0.30 (95% CI -0.41 to -0.19) for LOS. Generally, a decrease in resistance to most micro-organisms was observed. Despite an increase in the number of AMS studies conducted in Africa, the studies lack most of the quality design features for AMS studies. In conclusion, antimicrobial stewardship interventions are likely to be effective; however, efforts are still required to align the study design with the quality design features required for validity and to inform practice.
抗菌药物管理(AMS)干预措施旨在改善抗生素的使用,但它们的效果尚未完全明确。本综述旨在评估改善住院患者抗生素处方的干预措施的有效性。从 2010 年 1 月至 2022 年 7 月,我们系统性地检索了 PubMed、Embase、African Journals Online 和 Google Scholar 中的研究。如果研究报告了 AMS 干预措施对非洲住院患者相关结局的影响,则将其纳入。使用 Cochrane 有效实践和组织护理指南以及美国国立心肺血液研究所工具评估偏倚风险。研究结果以表格形式总结,并使用随机效应模型进行荟萃分析。共纳入 28 项研究,89%为干预前后无对照研究。大多数干预措施是多方面的,被证明是有效的,表现为提高了依从性、减少了抗生素的使用和费用,以及死亡率和住院时间(LOS)略有降低或没有差异。荟萃分析得出的死亡率相对风险为 0.82(95%置信区间 0.70-0.97),LOS 的标准化均数差为 -0.30(95%置信区间 -0.41 至 -0.19)。总体而言,大多数微生物的耐药性呈下降趋势。尽管在非洲开展的 AMS 研究数量有所增加,但这些研究缺乏大多数 AMS 研究所需的质量设计特征。结论:抗菌药物管理干预措施可能有效;但是,仍需要努力使研究设计与有效性所需的质量设计特征保持一致,并为实践提供信息。